About Algenesis
Algenesis is a private company based in San Diego, California. It has reported $11,215,151 raised in four offerings on Form D since April 2021. Its chief executive is Stephen Mayfield.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 18, 2024 | Oct 25, 2024 | $3,000,000fully sold | 22 | $136K | EquityRule 506(b) | Form D ↗ |
| Apr 28, 2023 | May 8, 2023amended Dec 18, 2023 | $5,000,000fully sold | 25 | $200K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| May 6, 2022 | Jul 11, 2022 | $847,125of $2.0M target | 25 | $33,885 | EquityRule 506(b) | Form D ↗ |
| Mar 25, 2021 | Apr 16, 2021 | $2,368,026of $2.4M target | 48 | $49,334 | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $11,215,151 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Algenesis's Form D filed Oct 25, 2024.
WH
Wolfgang Hafenmayer
Director
NS
Nicholas Sandland
Executive officer and director
VW
Veronica Wu
Director
DR
Daniel Rosen
Director
SM
Stephen Mayfield
CEO and director
DD
Daniel Dearen
Director
Earlier filings also listed Thomas Cooke (executive officer and director, last listed Dec 2023), Robert Pomeroy (promoter, last listed Dec 2023), Peter Morgan (executive officer and promoter, last listed Dec 2023), Nancy Dynan (director, last listed Dec 2023) and Michael Burkart (promoter, last listed Dec 2023).